SynthesisNature communications2025

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Jonathan Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.